Israel Biotech Fund I, L.P.

This profile gathers the share dealings of Israel Biotech Fund I, L.P. in Ayala Pharmaceuticals, Inc. Between 12 May 2020 and 7 February 2024, the trades on record add up to 13 filings.

Purchases make up the whole of the open-market record (3 purchases, €3.1M). The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 6 option exercises.

Most recently, on 12 February 2024, the filings show an option exercise worth €1.6M in Ayala Pharmaceuticals, Inc. The most recent open-market purchase was published on 31 October 2023, 1,089 days ago. Typically, a trade is published a median of 5 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.